gumarontinib   Click here for help

GtoPdb Ligand ID: 11623

Synonyms: glumetinib (pseoudo INN) | SCC-224 | SCC224
Compound class: Synthetic organic
Comment: Gumarontinib (SCC224) is an oral potent and highly selective c-MET inhibitor [1]. It was developed for potential to treat MET-dependent tumours.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 0
Rotatable bonds 4
Topological polar surface area 126.17
Molecular weight 459.12
XLogP 2.38
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cn1ncc(c1)c1ccc2n(c1)c(cn2)S(=O)(=O)n1ncc2c1cc(cn2)c1cnn(c1)C
Isomeric SMILES Cn1ncc(c1)c1ccc2n(c1)c(cn2)S(=O)(=O)n1ncc2c1cc(cn2)c1cnn(c1)C
InChI InChI=1S/C21H17N9O2S/c1-27-11-16(7-24-27)14-3-4-20-23-10-21(29(20)13-14)33(31,32)30-19-5-15(6-22-18(19)9-26-30)17-8-25-28(2)12-17/h3-13H,1-2H3
InChI Key RYBLECYFLJXEJX-UHFFFAOYSA-N
References
1. Ai J, Chen Y, Peng X, Ji Y, Xi Y, Shen Y, Yang X, Su Y, Sun Y, Gao Y et al.. (2018)
Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models.
Mol Cancer Ther, 17 (4): 751-762. [PMID:29237805]